Kara Swisher episode examines medical advances against chronic disease
Updated
Updated · CNN · May 2
Kara Swisher episode examines medical advances against chronic disease
11 articles · Updated · CNN · May 2
The CNN series' third episode airs at 9 p.m. ET Saturday, highlighting CRISPR and mRNA research, with HIV vaccines nearing trials and cancer vaccines already in clinical testing.
Experts say aging increases vulnerability to illnesses including dementia, heart disease, diabetes and cancer, while early-stage tools could help prevent or treat some conditions rather than simply extend lifespan.
The episode argues healthy longevity depends not only on new therapies but also on prevention, including exercise, Mediterranean-style diets, sleep and social connection, as chronic conditions affect most older US adults.
Could editing our genes to stop diseases like Alzheimer's accidentally create entirely new, unforeseen health problems?
As billionaires chase immortality, will breakthrough anti-aging therapies become a luxury only the ultra-rich can afford?
With science suggesting a biological limit to life, is the quest for immortality a futile distraction from living better?
Confronting the Chronic Disease Crisis: Pathways to Equitable Healthy Longevity in 2026
Overview
In April 2026, CNN premiered Kara Swisher's series highlighting the urgent chronic disease crisis driving early death and high healthcare costs, largely due to preventable conditions. The current reactive U.S. healthcare model undervalues prevention, prompting growing consumer and government investment in proactive health. Breakthroughs like CRISPR gene editing and mRNA vaccines offer hope but face challenges in scalability, ethics, and equitable access. Meanwhile, the booming longevity industry often prioritizes hype over evidence, overshadowing proven lifestyle pillars like nutrition and social connection. Countries like South Korea show that combining universal healthcare with prevention and technology can improve healthy lifespan, but income gaps and access disparities remain critical issues to address for truly inclusive longevity.